Viewing StudyNCT00101348



Ignite Creation Date: 2024-05-05 @ 11:40 AM
Last Modification Date: 2024-10-26 @ 9:11 AM
Study NCT ID: NCT00101348
Status: COMPLETED
Last Update Posted: 2014-06-11
First Post: 2005-01-07

Brief Title: Erlotinib and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Kidney Colorectal Head and Neck Pancreatic or Non-Small Cell Lung Cancer
Sponsor:
Organization: National Cancer Institute NCI